AUTHOR AND EDITOR INFORMATION

Section 1 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

INTRODUCTION

Section 2 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

Diabetes mellitus (DM) is an increasingly common medical condition affecting approximately 7% of the population of the United States. Of these 20 million people, it is estimated that nearly one third are unaware that they have the disease until faced with associated complications. The prevalence is even greater in hospitalized patients. The American Diabetes Association conservatively estimates that 12-25% of hospitalized adult patients have diabetes mellitus. With the increasing prevalence of diabetic patients undergoing surgery, and the increased risk of complications associated with diabetes mellitus, appropriate perioperative assessment and management are imperative.

An estimated 25% of diabetic patients will require surgery. Mortality rates in diabetic patients have been estimated to be up to 5 times greater than in nondiabetic patients, often related to the end-organ damage caused by the disease. Chronic complications resulting in microangiopathy (retinopathy, nephropathy, and neuropathy) and macroangiopathy (atherosclerosis) directly increase the need for surgical intervention and the occurrence of surgical complications due to infections and vasculopathies. Studies have shown that diabetes mellitus is an independent predictor of postoperative myocardial ischemia among patients undergoing cardiac and noncardiac surgery, in addition to postoperative infectious complications after cardiac surgery. Fortunately, tighter glycemic control has been shown to have a profound effect on reducing the incidence of many of these complications in a variety of surgical populations.

Although the benefits of tighter glycemic control have been well documented in many patient populations, the optimal range for glucose has yet to be well defined. Van den Berghe et al demonstrated a significant reduction in mortality with the use of a continuous insulin infusion to maintain glycemic control between 80-110 mg/dL.¹ However, recent studies have identified the potential cost of tight glycemic control because of the increased incidence of severe hypoglycemia.  Balancing the risks of hypoglycemia against the known benefits in morbidity and mortality is the goal, and, although intensive glycemic control continues to be standard of care, current consensus guidelines recommend less stringent glycemic goals, typically between 80-150 mg/dL. 

The ultimate goal in the management of diabetic patients is to achieve equivalent outcomes as those patients without diabetes mellitus. A meta-analysis of 15 studies reported that hyperglycemia increased both in-hospital mortality and incidence of heart failure in patients admitted for acute myocardial infarction, independent of a prior diagnosis of diabetes mellitus, demonstrating that the diagnosis of diabetes mellitus is not as important as controlling blood glucose concentrations. Comprehensive preoperative assessment and intensive intraoperative and postoperative management by a multidisciplinary team are recommended. A strong grasp of glucose insulin complexities and the effects of anesthesia and surgery are essential to optimizing outcomes.

PHYSIOLOGY OF GLUCOSE METABOLISM

Section 3 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

Glucose metabolism is largely a function of the liver, the pancreas, and, to a lesser degree, peripheral tissue. The liver plays a variety of roles in glucose regulation; it extracts glucose and stores it in the form of glycogen and performs gluconeogenesis as well as glycogenolysis. The pancreas secretes counterregulatory hormones: insulin from islet beta cells, which lowers blood glucose concentrations, and glucagon from islet alpha cells, which raises blood glucose concentrations. Additional contributors to glucose metabolism include the catabolic hormones: epinephrine, glucocorticoids, and growth hormone, which all raise blood glucose concentrations. Peripheral tissues participate in glucose metabolism by extracting glucose for energy needs, thus lowering blood glucose levels.

Appropriate glucose regulation preserves the availability of glucose to these tissues. For example, in the fasting state, insulin secretion decreases and catabolic hormone levels rise. In the case of absolute insulin deficiency (type 1 diabetes mellitus), unopposed catabolic action leads to hyperglycemia and, eventually, diabetic ketoacidosis. Type 2 diabetes mellitus is characterized by a peripheral resistance to insulin, and, in general, patients are less susceptible to developing ketoacidosis.

GENERAL PREOPERATIVE ASSESSMENT

Section 4 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

The foundation of the preoperative assessment is a comprehensive history and physical examination. Since estimates suggest that one third of diabetic patients are unaware of their disease, it may be prudent to screen all patients undergoing intermediate or major surgery by checking glycosylated hemoglobin (HbA1c). In addition to standard preoperative information, the following details of current diabetes management should be documented: duration of treatment, specific medication regimen, and issues with insulin resistance or hypersensitivity. If available, this information will be detailed in the patient's "diabetes journal.”

The history should assess for symptoms of cardiac, retinal, renal, neurological, and peripheral vascular disease. Since the mortality rate from heart disease is 2-4 times greater in diabetic patients, a comprehensive cardiac history should be completed for patients undergoing intermediate or major noncardiac surgery. In patients undergoing major vascular surgery, this should include either noninvasive myocardial function studies (dobutamine-stress echocardiography) or coronary artery angiography.

To summarize, the history should include the following:

• Suggestive symptoms (eg, polyuria/polydipsia, blurred vision)
• Eating patterns, nutritional status, exercise history, and weight history
• Current treatment of diabetes, including medication regimen, diet, exercise, and glucose monitoring results
• Frequency, severity, and etiology of acute complications (eg, ketoacidosis, hypoglycemia)
• Prior or current infections (eg, skin, foot, dental, genitourinary)
• Symptoms and treatment of chronic microvascular or macrovascular complications (eg, eye; kidney; nerve; genitourinary, bladder, and gastrointestinal function; heart; peripheral vascular; foot; and cerebrovascular complications)
• Nondiabetic medications that may affect blood glucose levels (eg, corticosteroids)
• Risk factors for atherosclerosis (eg, smoking, hypertension, obesity, dyslipidemia, family history)
• History and treatment of other conditions (eg, endocrine and eating disorders)
• Family history of diabetes mellitus and endocrine disorders
• Lifestyle, cultural, psychosocial, and economic factors that might influence diabetes mellitus management
• Tobacco, alcohol, and controlled substance use

The physical examination includes assessment for orthostatic hypotension, a potential sign of autonomic neuropathy. A fundoscopic examination may provide insight into the patient's risk of developing postoperative blindness, especially following prolonged spinal surgery in the prone position and cardiac surgery requiring cardiopulmonary bypass.

Type 1 diabetes mellitus is associated with a "stiff joint" syndrome, which poses a significant risk during airway management at the time of general anesthesia. The temporomandibular, atlantooccipital, and other cervical spine joints may be affected.  These patients also tend to have short stature and waxy skin, related to chronic hyperglycemia and nonenzymatic glycosylation of collagen and its deposition in joints. A positive "prayer sign" can be elicited on examination with the patient unable to approximate the palmar surfaces of the phalangeal joints while pressing their hands together; this represents cervical spine immobility and the potential for a difficult endotracheal intubation (see Media file 1). 

Further airway evaluation should include assessment of thyroid gland size, as patients with type 1 diabetes mellitus have a 15% association of other autoimmune diseases, such as Hashimoto thyroiditis and Graves disease.

Finally, the degree of preoperative neurological dysfunction is important to document, especially prior to regional anesthesia or peripheral nerve blocks, to assess the degree of subsequent nerve injury.

To summarize, the physical examination should include the following:

• Blood pressure (including orthostatic measurements)
• Fundoscopic examination
• Airway examination
• Thyroid palpation
• Cardiac examination
• Abdominal examination (hepatomegaly)
• Evaluation of pulses by palpation and with auscultation
• Feet examination
• Skin examination (insulin-injection sites)
• Neurological examination

GENERAL PREOPERATIVE MANAGEMENT

Section 5 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

Given that patients present preoperatively with a variety of diabetes mellitus regimens and are scheduled for surgery at varying times of the day, there is no established consensus for optimal perioperative management. However, using general management principles to minimize the likelihood of hypoglycemia and to limit the incidence of excessive hyperglycemia should guide decision making. Patients should communicate specifics of their surgical procedure to their endocrinologist or internist and, in conjunction with their anesthesiologist, be advised on modifications to their current regimen.

In general, on the day of surgery, patients on oral regimens should be advised to discontinue these medications. Secretagogues (eg, sulfonylureas, meglitinides) have the potential to cause hypoglycemia. In addition, sulfonylureas have been associated with interfering with ischemic myocardial preconditioning and may theoretically increase the risk of perioperative myocardial ischemia and infarction. Patients taking metformin should be advised to discontinue this drug preoperatively because of the risk of developing lactic acidosis. For these patients, short-acting insulin may be administered subcutaneously as a sliding scale or as a continuous infusion, to maintain optimal glucose control, depending on the type and duration of surgery.

Patients who are insulin-dependent are typically advised to reduce their bedtime dose of insulin the night prior to surgery to prevent hypoglycemia, while nil per os. Maintenance insulin may be continued, based on the history of glucose concentrations and the discretion of the advising clinician. Patients may be advised to consult with their anesthesiologist and diabetes-managing practitioner for individualized recommendations regarding their diabetes plan. Additionally, patients should be monitored preoperatively to assess for hyperglycemia and hypoglycemia.

METABOLIC RESPONSE TO ANESTHESIA AND SURGERY

Section 6 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

Surgery induces a considerable stress response mediated by the neuroendocrine system through the release of catecholamines, glucagon, and cortisol. The principle mechanism lies with the elevation of sympathetic tone with a subsequent release of cortisol and catecholamines during surgery. This compensatory mechanism in diabetic patients is impaired through a relative insulin deficiency (type 2) or an absolute insulin deficiency (type 1), necessitating supplemental insulin in the perioperative period.  Even nondiabetic patients, because of the considerable stress response, may become hyperglycemic perioperatively.

Anesthetic agents can affect glucose metabolism through the modulation of sympathetic tone; in vitro data suggest that inhalational agents suppress insulin secretion. The resulting relative insulin deficiency often leads to glucose dysregulation and hyperglycemia. This deficiency is compounded in diabetic patients, particularly those with insulin resistance, raising the risk of ketoacidosis. The use of regional anesthesia or peripheral nerve blocks may mitigate these concerns, but no data suggest that these forms of anesthesia improve postoperative survival in patients with diabetes mellitus.

GOALS OF PERIOPERATIVE GLYCEMIC CONTROL

Section 7 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

The goals for glycemic control are tailored to each patient based on a number of factors, such as nature of surgery, severity of underlying illness, modality used to achieve glycemic control, patient age, and sensitivity to insulin. Numerous clinical trials have involved various patient populations and examined the implications of perioperative hyperglycemia. Based on data derived from these studies, the American Diabetes Association has made recommendations for managing blood glucose levels in hospitalized patients with diabetes mellitus (see Table 1).
 
Table 1. Consensus Recommendations for Target Inpatient Blood Glucose Concentrations

An elevated HbA1c immediately before surgery may provide insight to a patient's risk for postoperative diabetic-related complications.  Prior to elective surgery, it is ideal for patients to have their HbA1c value at less than 6%.  It is unknown if tighter control may further reduce complications; however, this is at the cost of an increased risk of hypoglycemia. Less intensive glycemic control may be indicated in patients with severe or frequent episodes of hypoglycemia. Special populations, such as pregnant women with diabetes mellitus and elderly patients with diabetes mellitus, may require additional considerations. In addition, a plan for hypoglycemia should be delineated for individual patients.

Methods of Achieving Glycemic Control

Because of the numerous potential perioperative complications, close monitoring is imperative to maintain glycemic control, while minimizing hypoglycemia. After assessment, patients taking oral agents prior to surgery may be able to restart their previous regimen postoperatively.  However, appropriateness of oral agents needs to be reassessed because of potential complications (see Table 2). Intravenous insulin is the most flexible and readily titratable agent, making it an ideal modality for perioperative use.
 
Table 2. Considerations for Oral Agents

The length of surgery, the type of surgery, and the degree of glycemic dysregulation dictate the amount of supplemental insulin. It is recommended for patients with type 1 diabetes to schedule elective surgeries as the first case of the day to minimally disrupt their diabetes mellitus regimen. Depending on the length and extent of surgery, patients may be advised to administer one half of their daily dose of long-acting insulin and to arrive at the preoperative admitting area early enough to have their serum glucose monitored and to determine the need for intravenous dextrose, if needed, until the time of surgery.

Perioperative methods for achieving glycemic control are described below.

Establish separate intravenous access for a "piggyback" infusion of regular insulin (100 U per 100 mL 0.9 saline). The infusion rate can be determined by using the formula: insulin (U/hr) = serum glucose (mg/dL)/150.  Intra-arterial catheter placement is recommended to facilitate checking blood glucose concentrations every 1-2 hours intraoperatively and postoperatively. A second intravenous catheter may be used for intravascular volume replacement with a normal saline solution.

Numerous insulin protocols are available, with varying reliability and validation.  In addition, computer-based systems are available that calculate the continued dosing based on glucose concentration and rate of change.

DIABETIC COMPLICATIONS AND PERIOPERATIVE MANAGEMENT CONSIDERATIONS

Section 8 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

Table 3 summarizes the numerous complications of diabetes mellitus and the methods to minimize perioperative morbidity and mortality.

Table 3. Adult Diabetic Complications and Therapeutic Considerations/Strategies

ACE: Angiotensin II converting enzyme
ARB: Angiotensin receptor blocker
NSAIDs: Nonsteroidal anti-inflammatory drugs
* If no contraindication with agent shown to be effective in lowering cardiovascular events.
** Other disease states (critical illness) may necessitate higher amounts of protein.

Perioperative beta-blocker therapy should be considered for all diabetic patients undergoing intermediate or major risk noncardiac surgery as a means to decrease the incidence of postoperative myocardial ischemia and infarction. It is prudent to also assess all patients for orthostatic hypotension. This is easily diagnosed by performing a "tilt test" in the operating room, with patients receiving appropriate intravascular volume resuscitation prior to initiating any form of regional or general anesthesia. Patients suspected of gastroparesis should receive a prokinetic drug prior to general anesthesia to decrease the incidence of gastric acid aspiration.

Aseptic technique is particularly critical for patients with diabetes mellitus to decrease the incidence of postoperative infection. In addition, temperature control is also essential, as hypothermia can lead to peripheral insulin resistance, hyperglycemia, deceased wound healing, and infection. Hypothermia has been associated with an increase in wound infection following colon resection, craniotomy for cerebral aneurysm clipping, and open heart surgery with cardiopulmonary bypass.

Intraoperative management of intravascular volume may require the use of a central venous pressure catheter, a pulmonary artery catheter, or transesophageal echocardiography to optimally guide therapy and to prevent end-organ hypoperfusion. Arterial blood gas analysis should include assessment of blood glucose levels, in addition to sodium, potassium, and pH. Patients with type 1 diabetes are predisposed to developing ketoacidosis during periods of major stress; therefore, they should be monitored by arterial blood gas analysis during and after major surgery.

SUMMARY

Section 9 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

The increasing prevalence of diabetic patients undergoing surgery and the increased risk of complications associated with diabetes mellitus require optimal perioperative assessment and management. Diabetes management and its associated morbidities present a number of challenges, which are becoming an increasingly common medical issue. Data from numerous studies have demonstrated that diabetic patients are at an increased risk of significant morbidity and mortality. 

Although the benefits of tight glycemic control have been well documented in specific patient populations, the optimal range has yet to be well defined.  Intensive glycemic control necessitates close monitoring to reduce the incidence of hypoglycemia, which may negate the benefits of tight control. Computerized methods, such as the Glucommander®, appear to provide a more responsive alternative to insulin protocols. However, future research is still needed to help optimize the perioperative management of the diabetic patient.

ACKNOWLEDGMENTS

Section 10 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

The authors and editors of eMedicine gratefully acknowledge the contributions of previous coauthors, Raymond Cheung, MD, Benjamin Pace, MD, and Issac Sachmechi, MD, to the development and writing of this article.

MULTIMEDIA

Section 11 of 12  

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

Media file 1:  A positive "prayer sign" can be elicited on examination with the patient unable to approximate the palmar surfaces of the phalangeal joints while pressing their hands together; this represents cervical spine immobility and the potential for a difficult endotracheal intubation.
	View Full Size Image
Media type:  Photo

REFERENCES

Section 12 of 12

• Authors and Editors
• Introduction
• Physiology of Glucose Metabolism
• General Preoperative Assessment
• General Preoperative Management
• Metabolic Response to Anesthesia and Surgery
• Goals of Perioperative Glycemic Control
• Diabetic Complications and Perioperative Management Considerations
• Summary
• Acknowledgments
• Multimedia
• References

1. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. Feb 2 2006;354(5):449-61. [Medline].
2. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. May 2007;38(5):1655-711. [Medline].
3. Alberti KG, Gill GV, Elliott MJ. Insulin delivery during surgery in the diabetic patient. Diabetes Care. May-Jun 1982;5 Suppl 1:65-77. [Medline].
4. Alberti KG, Thomas DJ. The management of diabetes during surgery. Br J Anaesth. Jul 1979;51(7):693-710. [Medline].
5. Brooks-Brunn JA. Predictors of postoperative pulmonary complications following abdominal surgery. Chest. Mar 1997;111(3):564-71. [Medline].
6. Burgos LG, Ebert TJ, Asiddao C, et al. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology. Apr 1989;70(4):591-7. [Medline].
7. Butler SO, Btaiche IF, Alaniz C. Relationship between hyperglycemia and infection in critically ill patients. Pharmacotherapy. Jul 2005;25(7):963-76. [Medline].
8. Clarke RS. The hyperglycemic response to different types of surgery and anaesthesia. Br J Anaesth. 1979;51:693-710.
9. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. Feb 2004;27(2):553-91. [Medline].
10. Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. Oct 2005;28(10):2418-23. [Medline].
11. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. Feb 1999;67(2):352-60; discussion 360-2. [Medline].
12. Gavin LA. Perioperative management of the diabetic patient. Endocrinol Metab Clin North Am. Jun 1992;21(2):457-75. [Medline].
13. Goldberg NJ, Wingert TD, Levin SR, et al. Insulin therapy in the diabetic surgical patient: metabolic and hormone response to low dose insulin infusion. Diabetes Care. Mar-Apr 1981;4(2):279-84. [Medline].
14. Hall GM, Page SR. Diabetes and surgery. In: Hall GM, Page SR, eds. Emergency and Hospital Management. London: BMJ Publishing; 1999.
15. Hirsch IB, McGill JB, Cryer PE, et al. Perioperative management of surgical patients with diabetes mellitus. Anesthesiology. Feb 1991;74(2):346-59. [Medline].
16. Hollenberg M, Mangano DT, Browner WS, et al. Predictors of postoperative myocardial ischemia in patients undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA. Jul 8 1992;268(2):205-9. [Medline].
17. Hoogwerf BJ. Postoperative management of the diabetic patient. Med Clin North Am. Sep 2001;85(5):1213-28. [Medline].
18. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. Aug 2004;79(8):992-1000. [Medline].
19. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. Mar 30 2004;109(12):1497-502. [Medline].
20. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke. Feb 2004;35(2):363-4. [Medline].
21. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, et al. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J. Aug 2004;25(15):1341-62. [Medline].
22. Marks JB. Perioperative management of diabetes. Am Fam Physician. Jan 1 2003;67(1):93-100. [Medline].
23. Marso SP, Ellis SG, Gurm HS, et al. Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting. Am Heart J. Jun 2000;139(6):939-44. [Medline].
24. McAnulty GR, Robertshaw HJ, Hall GM. Anaesthetic management of patients with diabetes mellitus. Br J Anaesth. Jul 2000;85(1):80-90. [Medline].
25. National Institutes of Health. Glucontrol study: comparing the effects of two glucose regimens by insulin in two intensive care unit patients. December 2006;[Full Text].
26. Pezzarossa A, Taddei F, Cimicchi MC, et al. Perioperative management of diabetic subjects. Subcutaneous versus intravenous insulin administration during glucose-potassium infusion. Diabetes Care. Jan 1988;11(1):52-8. [Medline].
27. Raucoules-Aime M, Ichai C, Roussel LJ, et al. Comparison of two methods of i.v. insulin administration in the diabetic patient during the perioperative period. Br J Anaesth. Jan 1994;72(1):5-10. [Medline].
28. Raucoules-Aime M, Lugrin D, Boussofara M, et al. Intraoperative glycaemic control in non-insulin-dependent and insulin- dependent diabetes. Br J Anaesth. Oct 1994;73(4):443-9. [Medline].
29. Raucoules-Aime M, Roussel LJ, Rossi D, et al. Effect of severity of surgery on metabolic control and insulin requirements in insulin-dependent diabetic patients. Br J Anaesth. Feb 1995;74(2):231-3. [Medline].
30. Risum O, Abdelnoor M, Svennevig JL, et al. Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. Scand J Thorac Cardiovasc Surg. 1996;30(2):71-5. [Medline].
31. Rodriguez BL, Lau N, Burchfiel CM, et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care. Aug 1999;22(8):1262-5. [Medline].
32. Sinert R, Adamson O, Johnson E. The incidence of previously undiagnosed diabetes mellitus in patients with soft tissue infections. Acad Emerg Med. May 2001;8(5):538.
33. Standards of medical care in diabetes--2008. Diabetes Care. Jan 2008;31 Suppl 1:S12-54. [Medline].
34. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. Mar 2002;87(3):978-82. [Medline].
35. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. Nov 8 2001;345(19):1359-67. [Medline].
36. Vanhaeverbeek M. Peri-operative care: management of the diabetic patient. A novel controversy about tight glycemic control. Acta Clin Belg. 1997;52(5):313-9. [Medline].

Article Last Updated: Sep 4, 2008